spacer

CDC HomeHIV/AIDS > Fact Sheets

  Topics
space
arrow African Americans
space
arrow Basic Information
space
arrow Funding
space
arrow Global HIV/AIDS
space
arrow Hispanics/Latinos
space
arrow Men Who Have Sex with Men (MSM)
space
arrow Statistics & Surveillance
space
arrow Testing
space
arrow Women
space
arrow More Topics...
space
  Resources by Format
space
arrow Questions & Answers
space
arrow Fact Sheets
space
arrow Brochures
space
arrow Slide Sets
space
arrow Podcasts
space
arrow Software
space
arrow Journal Articles
space
arrow Reports
space
arrow Recommendations & Guidelines
space
arrow Other Documents
space
LEGEND:
PDF Icon   Link to a PDF document
Non-CDC Web Link   Link to non-governmental site and does not necessarily represent the views of the CDC
Adobe Acrobat (TM) Reader needs to be installed on your computer in order to read documents in PDF format. Download the Reader.
spacer spacer
spacer
Skip Nav
spacer
Coinfection with HIV and Hepatitis C Virus
spacer
spacer
View PDF PDF Icon | En español November 2005

Overview

  • Persons with HIV, especially injection drug users, may also be infected with the hepatitis C virus (HCV).
  • HCV infection is more serious in persons with HIV.
  • Many persons with HCV don’t have any symptoms.
  • HCV infection can be treated

Injecting drugs is one of the main ways people become infected with HIV. It is also the main way of becoming infected with the hepatitis C virus (HCV). In fact, 50%-90% of HIV-infected injection drug users are also infected with hepatitis C.

HCV infection is more serious in HIV-infected persons.* It leads to liver damage more quickly. Coinfection with HCV may also affect the treatment of HIV infection. Therefore, it’s important for HIV-infected persons to know whether they are also infected with HCV and, if they aren’t, to take steps to prevent infection.

Many people with hepatitis C don’t have any symptoms of the disease. So your doctor or other health care provider will have to test your blood to check for the virus. If you test positive, he or she may also do a liver biopsy to determine the amount of damage to your liver.

Chronic† hepatitis C can be treated successfully, even in HIV-infected persons. Treatment for chronic hepatitis C is with a single drug or combination of two drugs. Treatment will usually take 6-12 months. You should drink little or no alcohol during treatment and may be advised not to have alcohol ever again. Vaccination against hepatitis A and hepatitis B is also recommended.

*It is not known yet whether coinfection with HCV makes HIV disease progress faster.
†”Chronic” means having the disease for a long time.

Other Ways of Becoming Infected with HCV

There are other ways of becoming infected with HCV. Persons with hemophilia who received clotting factor concentrates before 1987 commonly have HCV infection. Becoming infected through sexual contact is possible, but the risk is much lower than the risk for HIV. Mothers can pass the infection to their newborn babies, but here too the risk is less than that for HIV.

How to Prevent HCV Infection

The best way to prevent infection with HCV is to stop injecting drugs or never to start. Substance abuse programs may help. If you continue to inject drugs, always use new, sterile syringes and never reuse or share syringes, needles, water or drug preparation equipment. Do not share toothbrushes, razors and other items that might be contaminated with blood. Tattooing or body piercing may also put you at increased risk for infection with any bloodborne pathogen if dirty needles or other instruments are used. Practice safer sex.

Liver Biopsy

During a liver biopsy, a tiny piece of your liver is removed through a needle. The tiny piece (or specimen) is then checked for amount of liver damage.

Treating HCV Infection

Alpha interferon or pegylated interferon alone, or one of these in combination with ribavirin are the drugs given to patients with chronic hepatitis C who are at greatest risk for progression to serious disease. Treatment is not always successful, but even HIV-infected patients may benefit from treatment. Your doctor or other health care provider will need to make the final decision about if and when you should receive treatment.

spacer
Last Modified: March 8, 2007
Last Reviewed: March 8, 2007
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
spacer
spacer
spacer
Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
spacer USA.gov: The U.S. Government's Official Web PortalDHHS Department of Health
and Human Services